Table 7.
Percentage sensitivity patterns of most prevalent pathogens to selected antimicrobials
| Region |
Africa |
South-East Asia |
|||||
|---|---|---|---|---|---|---|---|
| Organism | Antimicrobial | Adejuyigbe et al (20) | Muhe et al (27) | Mathur et al (37) | Panigrahi et al (39) | Darmstadt et al (35) | Tallur et al (41) |
|
Escherichia coli |
Amoxycillin (AMX) |
60.0 |
— |
— |
— |
— |
— |
| Ampicillin (AMP) |
40.0 |
100.0 |
— |
— |
100.0 |
29.0 |
|
| Cefotaxime (CTX) |
— |
— |
— |
— |
— |
100.0 |
|
| Ceftazidime (CAZ) |
— |
100.0 |
— |
— |
100.0 |
— |
|
| Ceftriaxone (CRO) |
— |
— |
— |
— |
100.0 |
100.0 |
|
| Ciprofloxacin (CIP) |
— |
— |
— |
— |
100.0 |
— |
|
| Gentamicin (GEN) |
80.0 |
100.0 |
— |
— |
100.0 |
71.0 |
|
| Imipenem (IMP) |
100.0 |
— |
|||||
|
Staphylococcus aureus |
Amoxycillin (AMX) |
73.0 |
— |
— |
— |
— |
— |
| Ampicillin (AMP) |
— |
— |
— |
— |
0.0 |
21.0 |
|
| Cefotaxime (CTX) |
— |
— |
— |
— |
— |
— |
|
| Ceftazidime (CAZ) |
— |
— |
— |
— |
66.7 |
— |
|
| Ceftriaxone (CRO) |
— |
— |
— |
— |
90.0 |
— |
|
| Ciprofloxacin (CIP) |
— |
— |
— |
— |
80.0 |
— |
|
| Gentamicin (GEN) |
85.8 |
— |
— |
— |
90.0 |
29.0 |
|
| Imipenem (IMP) |
— |
— |
— |
— |
90.0 |
— |
|
|
Klebsiella species* |
Amoxycillin (AMX) |
0.0 |
— |
— |
— |
— |
— |
| Ampicillin (AMP) |
— |
— |
10.0 |
— |
0.0 |
25.5 |
|
| Cefotaxime (CTX) |
— |
— |
— |
— |
— |
76.5 |
|
| Ceftazidime (CAZ) |
— |
— |
— |
22.0 |
33.3 |
— |
|
| Ceftriaxone (CRO) |
— |
— |
71.4 |
— |
33.3 |
81.0 |
|
| Ciprofloxacin (CIP) |
— |
— |
64.8 |
11.0 |
66.7 |
— |
|
| Gentamicin (GEN) |
100.0 |
— |
42.8 |
— |
66.7 |
59.5 |
|
| Imipenem (IMP) | — | 100.0 | — | 100.0 | — | ||
*Averages were taken when more than one variant’s sensitivity patterns were reported.